Medtech for urgent oncology care pathways (Neutrocheck, Aster platform).
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Funding round UK medtech 52North raised USD 6M co-led by KHP Ventures and Cedars-Sinai, plus a USD 1.5M NIHR grant, to advance its oncology diagnostics. | $6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.